JOHN FARMER to Coronary Disease
This is a "connection" page, showing publications JOHN FARMER has written about Coronary Disease.
Connection Strength
1.037
-
The Heart Protection Study: expanding the boundaries for high-risk coronary disease prevention. Am J Cardiol. 2003 Jul 03; 92(1A):3i-9i.
Score: 0.162
-
Benefits of simvastin in cholesterol lowering. Curr Atheroscler Rep. 2003 Mar; 5(2):93-4.
Score: 0.158
-
Benefits of atorvastatin in cholesterol lowering. Curr Atheroscler Rep. 2003 Mar; 5(2):94-5.
Score: 0.158
-
Platelet inhibition with tirofiban early during percutaneous coronary intervention: dosing revisited. Catheter Cardiovasc Interv. 2002 Aug; 56(4):474-7.
Score: 0.152
-
The renin angiotensin system as a risk factor for coronary artery disease. Curr Atheroscler Rep. 2001 Mar; 3(2):117-24.
Score: 0.138
-
Coronary heart disease: clinical trials review. Curr Atheroscler Rep. 2000 May; 2(3):189-93.
Score: 0.130
-
Diabetic dyslipidemia and atherosclerosis: evidence from clinical trials. Curr Atheroscler Rep. 2007 Aug; 9(2):162-8.
Score: 0.054
-
Influence of low HDL on progression of coronary artery disease and response to fluvastatin therapy. Circulation. 1999 Feb 16; 99(6):736-43.
Score: 0.030
-
Images in cardiovascular medicine. Fistula between left main, left anterior descending, and pulmonary arteries. Circulation. 1998 May 26; 97(20):2091-2.
Score: 0.028
-
Effects of lipid lowering therapy on progression of coronary and carotid artery disease. Curr Opin Lipidol. 1997 Dec; 8(6):354-61.
Score: 0.027